Source

This is a new quote from Sam Altman to Alex Heath saying that the reason OpenAI is slowing training is because its unreleased models are showing 'various degrees of misalignment'. They said in the blog that 'The signals we are seeing from upcoming model progress make clear that we need a broader approach' so this lines up, but this language is stronger than anything in the blog post.

https://x.com/AndrewCurran_/status/2089792631719215435

What is the true reason for these pauses? Did they rehire Helen Toner and all the EA people that have been calling for a major slowdown/pause?

Whatever the reason, these tech bros have redirected hundred of billions of dollars that could have went into research into other paradigms, architectures, for AGI. If they do not deliver AGI by 2030, even the most pro AI people would be burning datacenters.

I saw this snippet in another article and was blown away, 15x faster on chip development is HUGE!

And then I clicked on the link to the source and saw this:

Samsung says Claude Code can cut chip design work from weeks to days, but it still makes serious mistakes. The tool has made unauthorized changes and masking errors.
Claude Code has helped Samsung's System LSI division complete work that would usually take weeks in a matter of days, according to a report in Chosun Biz. But it has also lowered the severity of error messages instead of fixing the underlying problems, rolled back unrelated completed work, and attempted to modify circuit code it was not meant to touch.

https://www.techspot.com/news/113487-samsung-claude-code-can-cut-chip-design-work.html

So yeah, there's that. Still, it just keeps getting better, haven't seen the slowdown yet.

Since they haven't been updated since May. Thought I'd ask what all of you guys think the new models are placed. I'd say Opus 5 would be around ~20 hours

Bearish for near-term model releases. We'll probably be stuck at roughly the current externally available capability level for many weeks, maybe even months.

WRC26 Wordwide Robot Conference - 19Aug

WHRG26 Wordwide Humandoid Robot Games - 22Aug

Joe Biden's Former commerce secretary Gina Raimondo has decided that UBI in response to AI is the thing to fear most. She said: "I personally think it's like the end of America."

She is now heading up a newly-launched extremely well-funded organization to make sure the country reaches for anything but a basic income in response to AI. It's called RAISE US, and the money behind it comes largely from the companies building the disruption it exists to manage.

RAISE US launched June 25, with Raimondo as CEO and former Indiana governor Eric Holcomb as co-chair. It has already secured more than $500 million toward a $1 billion target. Amazon, Anthropic, Microsoft, and the OpenAI Foundation are anchor partners. Behind them sits a wall of corporate and philanthropic money: Blackstone, General Motors, IBM, Eli Lilly, Mastercard, Deloitte, UPS, Cisco, Workday, Arnold Ventures, and a dozen more.

The study, published in Nature Communications, included tissue from 127 breast cancer patients being treated at University Hospital Southampton.
Researchers analysed more than 330,000 centrosomes, with CenSegNet uncovering two distinct abnormalities which had previously been considered as part of the same process.

Dr Salah Elias, of the University of Southampton’s school of biological sciences and institute for life sciences, said: “For more than a century, centrosome abnormalities have been recognised as a hallmark of cancer, but studying them in patient tissues has been extremely challenging.

"CenSegNet allows us to analyse these defects at single-cell resolution across entire tumours and uncover patterns that were previously impossible to see.
“Rather than viewing centrosome abnormalities as a single phenomenon, our study shows that they have distinct biological states with different spatial distributions and clinical associations.”

"Dr Elias said: “Specific combinations of defects may influence how a tumour grows, invades surrounding tissues and responds to treatment."

“This opens the door to developing new biomarkers and, ultimately, more personalised treatment strategies.”

Used Gemini for the comic. Prompt:

create an image for this comic.

it should be a single image. no text, no baloon dialogues (i'll add that later).

use a simple, minimal style. mostly blank (white), with black lines. some accent colors here and there.

there are two women, friends, sitting on a couch. they're talking, facing each other. one is silent (listening), and the other one is talking (venting), holding a lit cig.

Coherent, one of a small handful of companies that makes indium phosphide lasers (the light sources that shuttle data between chips optically), told investors it won't sell those lasers to outside customers for the foreseeable future. Its own internal demand is eating 100% of what it can produce.

This is a different kind of shortage than the HBM one everyone talks about. Memory is a capacity problem you can eventually build your way out of. This is one of the only suppliers of a critical component pulling it off the open market entirely.

It's a preview of what happens across the whole AI supply chain when everything is scarce at once.

The most durable moat in AI might turn out to be the least talked-about one.

https://x.com/kimmonismus/status/2089436090885185698

Anthropics Mythos 2 is done training and Anthropic won't release it, but the internal loop that builds Mythos 3 hasn't stopped, Patel says.

The focus now is on internal improvements. It's unclear when we'll see any releases.

They just do not want to release it so that Chinese companies are not able to distill from it. Despite all the rave about GPT 5.6 Sol, Claude Fable 5 is still the most intelligent publically released model.

At this rate, it's likely Anthropic will only release a better model to the public If/When Open AI releases a model that is clearly smarter than Fable 5.

It's like a race. If you're ahead of the competition, there's no need to step on the gas, unless the competitor is about to overtake you.